BACKGROUND AND PURPOSE: Chemokines and their receptors form an intricate interaction and signalling network that plays critical roles in various physiological and pathological cellular processes. The high promiscuity and apparent redundancy of this network makes probing individual chemokine/receptor interactions and functional effects, as well as targeting individual receptor axes for therapeutic applications, challenging. Despite poor sequence identity, the N-terminal regions of chemokines, which play a key role in their activity and selectivity, contain several conserved features. Thus far little is known regarding the molecular basis of their interactions with typical and atypical chemokine receptors or the conservation of their contributions across chemokine-receptor pairs. EXPERIMENTAL APPROACH: We used a broad panel of chemokine variants and modified peptides derived from the N-terminal region of chemokines CXCL12, CXCL11 and vCCL2, to compare the contributions of various features to binding and activation of their shared receptors, the two typical, canonical G protein-signalling receptors, CXCR4 and CXCR3, as well as the atypical scavenger receptor CXCR7/ACKR3, which shows exclusively arrestin-dependent activity. KEY RESULTS: We provide molecular insights into the plasticity of the ligand-binding pockets of these receptors, their chemokine binding modes and their activation mechanisms. Although the chemokine N-terminal region is a critical determinant, neither the most proximal residues nor the N-loop are essential for binding and activation of ACKR3, as distinct from binding and activation of CXCR4 and CXCR3. CONCLUSION AND IMPLICATIONS: These results suggest a different interaction mechanism between this atypical receptor and its ligands and illustrate its strong propensity to activation.
BACKGROUND AND PURPOSE: Chemokines and their receptors form an intricate interaction and signalling network that plays critical roles in various physiological and pathological cellular processes. The high promiscuity and apparent redundancy of this network makes probing individual chemokine/receptor interactions and functional effects, as well as targeting individual receptor axes for therapeutic applications, challenging. Despite poor sequence identity, the N-terminal regions of chemokines, which play a key role in their activity and selectivity, contain several conserved features. Thus far little is known regarding the molecular basis of their interactions with typical and atypical chemokine receptors or the conservation of their contributions across chemokine-receptor pairs. EXPERIMENTAL APPROACH: We used a broad panel of chemokine variants and modified peptides derived from the N-terminal region of chemokines CXCL12, CXCL11 and vCCL2, to compare the contributions of various features to binding and activation of their shared receptors, the two typical, canonical G protein-signalling receptors, CXCR4 and CXCR3, as well as the atypical scavenger receptor CXCR7/ACKR3, which shows exclusively arrestin-dependent activity. KEY RESULTS: We provide molecular insights into the plasticity of the ligand-binding pockets of these receptors, their chemokine binding modes and their activation mechanisms. Although the chemokine N-terminal region is a critical determinant, neither the most proximal residues nor the N-loop are essential for binding and activation of ACKR3, as distinct from binding and activation of CXCR4 and CXCR3. CONCLUSION AND IMPLICATIONS: These results suggest a different interaction mechanism between this atypical receptor and its ligands and illustrate its strong propensity to activation.
Authors: Karl Balabanian; Bernard Lagane; Simona Infantino; Ken Y C Chow; Julie Harriague; Barbara Moepps; Fernando Arenzana-Seisdedos; Marcus Thelen; Françoise Bachelerie Journal: J Biol Chem Date: 2005-08-17 Impact factor: 5.157
Authors: Maikel Wijtmans; David Maussang; Francesco Sirci; Danny J Scholten; Meritxell Canals; Azra Mujić-Delić; Milagros Chong; Kristell L S Chatalic; Hans Custers; Elwin Janssen; Chris de Graaf; Martine J Smit; Iwan J P de Esch; Rob Leurs Journal: Eur J Med Chem Date: 2012-02-27 Impact factor: 6.514
Authors: P Proost; E Schutyser; P Menten; S Struyf; A Wuyts; G Opdenakker; M Detheux; M Parmentier; C Durinx; A M Lambeir; J Neyts; S Liekens; P C Maudgal; A Billiau; J Van Damme Journal: Blood Date: 2001-12-15 Impact factor: 22.113
Authors: T N Kledal; M M Rosenkilde; F Coulin; G Simmons; A H Johnsen; S Alouani; C A Power; H R Lüttichau; J Gerstoft; P R Clapham; I Clark-Lewis; T N Wells; T W Schwartz Journal: Science Date: 1997-09-12 Impact factor: 47.728
Authors: P Proost; S Struyf; D Schols; C Durinx; A Wuyts; J P Lenaerts; E De Clercq; I De Meester; J Van Damme Journal: FEBS Lett Date: 1998-07-31 Impact factor: 4.124
Authors: John S Burg; Jessica R Ingram; A J Venkatakrishnan; Kevin M Jude; Abhiram Dukkipati; Evan N Feinberg; Alessandro Angelini; Deepa Waghray; Ron O Dror; Hidde L Ploegh; K Christopher Garcia Journal: Science Date: 2015-03-06 Impact factor: 47.728
Authors: Jennifer M Burns; Bretton C Summers; Yu Wang; Anita Melikian; Rob Berahovich; Zhenhua Miao; Mark E T Penfold; Mary Jean Sunshine; Dan R Littman; Calvin J Kuo; Kevin Wei; Brian E McMaster; Kim Wright; Maureen C Howard; Thomas J Schall Journal: J Exp Med Date: 2006-08-28 Impact factor: 14.307
Authors: Ahmed M Elmansi; Mohamed E Awad; Nada H Eisa; Dmitry Kondrikov; Khaled A Hussein; Alexandra Aguilar-Pérez; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Sadanand Fulzele; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Brian F Volkman; William D Hill Journal: Pharmacol Ther Date: 2019-02-10 Impact factor: 12.310
Authors: Natasha A Moussouras; Gertrud M Hjortø; Francis C Peterson; Martyna Szpakowska; Andy Chevigné; Mette M Rosenkilde; Brian F Volkman; Michael B Dwinell Journal: Biochemistry Date: 2020-03-26 Impact factor: 3.162
Authors: Steven J Simmons; Chicora F Oliver; Nicholas S McCloskey; Allen B Reitz; Sunil U Nayak; Mia N Watson; Scott M Rawls Journal: Drug Alcohol Depend Date: 2021-11-27 Impact factor: 4.492